Skip to main content

Advertisement

Table 1 General and metabolic characteristics

From: SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice

Variable Con Con + dapa Db Db + dapa
Weekly food intake (g) 20.6 ± 0.3 23.9 ± 0.2 37.6 ± 1.7#† 49.8 ± 2.4*
Weight gain (g) 3.8 ± 0.4 2.5 ± 0.4 − 5.2 ± 1.4* 5.4 ± 0.8‡†
Subcutaneous Fat (g) 906 ± 70 938 ± 111 3415 ± 339* 4357 ± 204*
Epididymal Fat (g) 1055 ± 63 1117 ± 119 2085 ± 211#† 2442 ± 102#†
Mesenteric fat (g) 541 ± 35 581 ± 44 957 ± 123* 1331 ± 92*
PVAT (g) 30 ± 2 26 ± 2 36 ± 5 47±5*
  1. Values are mean ± SEM
  2. PVAT perivascular adipose tissue; n = 11–12/group
  3. * p < 0.05 vs all other groups
  4. #p < 0.05 vs Con
  5. p < 0.05 vs Con + dapa
  6. p < 0.05 vs Db